Press Release

View printer-friendly version << Back
Nuvectra to Present at Two Upcoming Investor Conferences

PLANO, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at two upcoming investor conferences.

Event: Cowen and Company 38th Annual Health Care Conference 
Date: Monday, March 12, 2018 
Time: 2:10 p.m. ET
Location: The Boston Marriott Copley Place, Boston
Event: 17th Annual Needham Healthcare Conference
Date: Tuesday, March 27, 2018
Time 4:00 p.m. ET
Location: Westin Grand Central Hotel, New York

A webcast of each of the Company’s presentations will be available by visiting the investor relations section of Nuvectra’s website at A webcast replay of the presentation will be available for 90 days.

About Nuvectra Corporation

NuvectraTM is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder, and deep brain stimulation (DBS) for the treatment of Parkinson’s Disease. In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at

Company Contacts:
Nuvectra Corporation

Walter Berger, COO & CFO 
(214) 474-3102

Investor Contacts:
The Ruth Group

Tram Bui / Brian Johnston
(646) 536-7035 / 7028

Primary Logo

Nuvectra Corporation